• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

机械通气急性呼吸窘迫综合征患者动脉二氧化碳分压的时变与 28 天死亡率的关系。

Association between the time-varying arterial carbon dioxide pressure and 28-day mortality in mechanically ventilated patients with acute respiratory distress syndrome.

机构信息

Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, School of Medicine, Zhongda Hospital, Southeast University, Nanjing, Jiangsu, 210009, China.

Department of Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215000, China.

出版信息

BMC Pulm Med. 2023 Apr 19;23(1):129. doi: 10.1186/s12890-023-02431-6.

DOI:10.1186/s12890-023-02431-6
PMID:37076846
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10113995/
Abstract

BACKGROUND

Recent studies have shown an association between baseline arterial carbon dioxide pressure (PaCO) and outcomes in patients with acute respiratory distress syndrome (ARDS). However, PaCO probably varies throughout the disease, and few studies have assessed the effect of longitudinal PaCO on prognosis. We thus aimed to investigate the association between time-varying PaCO and 28-day mortality in mechanically ventilated ARDS patients.

METHODS

In this retrospective study, we included all adult (≥ 18 years) patients diagnosed with ARDS who received mechanical ventilation for at least 24 h at a tertiary teaching hospital between January 2014 and March 2021. Patients were excluded if they received extracorporeal membrane oxygenation (ECMO). Demographic data, respiratory variables, and daily PaCO were extracted. The primary outcome was 28-day mortality. Time-varying Cox models were used to estimate the association between longitudinal PaCO measurements and 28-day mortality.

RESULTS

A total of 709 patients were eligible for inclusion in the final cohort, with an average age of 65 years, of whom 70.7% were male, and the overall 28-day mortality was 35.5%. After adjustment for baseline confounders, including age and severity of disease, a significant increase in the hazard of death was found to be associated with both time-varying PaCO (HR 1.07, 95% CI 1.03-1.11, p<0.001) and the time-varying coefficient of variation for PaCO (HR 1.24 per 10% increase, 95% CI 1.10-1.40, p<0.001) during the first five days of invasive mechanical ventilation. The cumulative proportion of exposure to normal PaCO (HR 0.72 per 10% increase, 95% CI 0.58-0.89, p = 0.002) was associated with 28-day mortality.

CONCLUSION

PaCO should be closely monitored in mechanically ventilated ARDS patients. The association between PaCO and 28-day mortality persisted over time. Increased cumulative exposure to normal PaCO was associated with a decreased risk of death.

摘要

背景

最近的研究表明,动脉血二氧化碳分压(PaCO)基线与急性呼吸窘迫综合征(ARDS)患者的结局之间存在关联。然而,PaCO 可能在整个疾病过程中发生变化,很少有研究评估纵向 PaCO 对预后的影响。因此,我们旨在研究机械通气的 ARDS 患者中时变 PaCO 与 28 天死亡率之间的关系。

方法

在这项回顾性研究中,我们纳入了 2014 年 1 月至 2021 年 3 月期间在一家三级教学医院接受至少 24 小时机械通气治疗的所有成人(≥18 岁)ARDS 患者。如果患者接受体外膜氧合(ECMO),则将其排除在外。提取人口统计学数据、呼吸变量和每日 PaCO。主要结局为 28 天死亡率。使用时变 Cox 模型估计纵向 PaCO 测量值与 28 天死亡率之间的关系。

结果

共有 709 名患者符合最终队列的入选标准,平均年龄为 65 岁,其中 70.7%为男性,总 28 天死亡率为 35.5%。在调整了年龄和疾病严重程度等基线混杂因素后,发现死亡风险的显著增加与时变 PaCO(HR 1.07,95%CI 1.03-1.11,p<0.001)和 PaCO 时变变异系数(HR 1.24/每增加 10%,95%CI 1.10-1.40,p<0.001)在机械通气的前五天内呈正相关。接触正常 PaCO 的累积比例(HR 每增加 10%,0.58-0.89,p=0.002)与 28 天死亡率相关。

结论

机械通气的 ARDS 患者应密切监测 PaCO。PaCO 与 28 天死亡率之间的关联随着时间的推移而持续存在。累积接触正常 PaCO 的增加与死亡风险降低相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ba/10114371/08a75ffe2559/12890_2023_2431_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ba/10114371/76cd7d1088ea/12890_2023_2431_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ba/10114371/177162422c7b/12890_2023_2431_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ba/10114371/08a75ffe2559/12890_2023_2431_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ba/10114371/76cd7d1088ea/12890_2023_2431_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ba/10114371/177162422c7b/12890_2023_2431_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ba/10114371/08a75ffe2559/12890_2023_2431_Fig3_HTML.jpg

相似文献

1
Association between the time-varying arterial carbon dioxide pressure and 28-day mortality in mechanically ventilated patients with acute respiratory distress syndrome.机械通气急性呼吸窘迫综合征患者动脉二氧化碳分压的时变与 28 天死亡率的关系。
BMC Pulm Med. 2023 Apr 19;23(1):129. doi: 10.1186/s12890-023-02431-6.
2
Association Between Dyscapnia, Ventilatory Variables, and Mortality in Patients With Acute Respiratory Distress Syndrome-A Retrospective Cohort Study.急性呼吸窘迫综合征患者二氧化碳潴留、通气变量与死亡率之间的关联——一项回顾性队列研究
J Intensive Care Med. 2024 Nov;39(11):1099-1108. doi: 10.1177/08850666241252741. Epub 2024 Jun 7.
3
Targeting arterial partial pressure of carbon dioxide in acute respiratory distress syndrome patients using extracorporeal carbon dioxide removal.应用体外二氧化碳清除技术靶向急性呼吸窘迫综合征患者的动脉血二氧化碳分压。
Artif Organs. 2022 Apr;46(4):677-687. doi: 10.1111/aor.14127. Epub 2021 Nov 29.
4
Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.雾化肝素治疗急性呼吸窘迫综合征患者或有急性呼吸窘迫综合征风险患者的多中心、随机、双盲、安慰剂对照 3 期试验。
Lancet Respir Med. 2021 Apr;9(4):360-372. doi: 10.1016/S2213-2600(20)30470-7. Epub 2021 Jan 22.
5
Extracorporeal carbon dioxide removal requirements for ultraprotective mechanical ventilation: Mathematical model predictions.超保护性机械通气的体外二氧化碳清除需求:数学模型预测
Artif Organs. 2020 May;44(5):488-496. doi: 10.1111/aor.13601. Epub 2019 Dec 15.
6
Extracorporeal Carbon Dioxide Removal in Patients with Acute Respiratory Distress Syndrome or Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.急性呼吸窘迫综合征或慢性阻塞性肺疾病患者的体外二氧化碳清除:系统评价与荟萃分析
Blood Purif. 2023;52(2):103-113. doi: 10.1159/000525983. Epub 2022 Aug 29.
7
Validation of RESP and PRESERVE score for ARDS patients with pumpless extracorporeal lung assist (pECLA).验证无泵体外肺辅助(pECLA)治疗急性呼吸窘迫综合征(ARDS)患者的 RESP 和 PRESERVE 评分。
BMC Anesthesiol. 2020 May 2;20(1):102. doi: 10.1186/s12871-020-01010-0.
8
Feasibility and safety of low-flow extracorporeal CO removal managed with a renal replacement platform to enhance lung-protective ventilation of patients with mild-to-moderate ARDS.应用肾脏替代平台管理低流量体外 CO 去除对轻中度 ARDS 患者实施肺保护性通气的可行性和安全性。
Crit Care. 2018 May 10;22(1):122. doi: 10.1186/s13054-018-2038-5.
9
Associations between ventilator settings during extracorporeal membrane oxygenation for refractory hypoxemia and outcome in patients with acute respiratory distress syndrome: a pooled individual patient data analysis : Mechanical ventilation during ECMO.体外膜肺氧合治疗难治性低氧血症时呼吸机设置与急性呼吸窘迫综合征患者预后的关系:一项汇总个体患者数据分析:体外膜肺氧合期间的机械通气
Intensive Care Med. 2016 Nov;42(11):1672-1684. doi: 10.1007/s00134-016-4507-0. Epub 2016 Sep 1.
10
The impacts of baseline ventilator parameters on hospital mortality in acute respiratory distress syndrome treated with venovenous extracorporeal membrane oxygenation: a retrospective cohort study.基线呼吸机参数对接受静脉-静脉体外膜肺氧合治疗的急性呼吸窘迫综合征患者住院死亡率的影响:一项回顾性队列研究。
BMC Pulm Med. 2017 Dec 8;17(1):181. doi: 10.1186/s12890-017-0520-5.

引用本文的文献

1
Association between diastolic blood pressure during the first 24 h and 28-day mortality in patients with septic shock: a retrospective observational study.在脓毒性休克患者中,前 24 小时和 28 天死亡率与舒张期血压之间的关系:一项回顾性观察研究。
Eur J Med Res. 2023 Sep 9;28(1):329. doi: 10.1186/s40001-023-01315-z.

本文引用的文献

1
Longitudinal ventilatory ratio monitoring for COVID-19: its potential in predicting severity and assessing treatment response.COVID-19的纵向通气比率监测:其在预测严重程度和评估治疗反应方面的潜力。
Crit Care. 2021 Oct 20;25(1):366. doi: 10.1186/s13054-021-03768-2.
2
Longitudinal respiratory subphenotypes in patients with COVID-19-related acute respiratory distress syndrome: results from three observational cohorts.COVID-19 相关急性呼吸窘迫综合征患者的纵向呼吸亚表型:来自三个观察队列的结果。
Lancet Respir Med. 2021 Dec;9(12):1377-1386. doi: 10.1016/S2213-2600(21)00365-9. Epub 2021 Oct 13.
3
An Exploratory Analysis of the Association between Hypercapnia and Hospital Mortality in Critically Ill Patients with Sepsis.
探讨分析合并脓毒症的危重症患者高碳酸血症与住院死亡率之间的关系。
Ann Am Thorac Soc. 2022 Feb;19(2):245-254. doi: 10.1513/AnnalsATS.202102-104OC.
4
Longitudinal changes in compliance, oxygenation and ventilatory ratio in COVID-19 versus non-COVID-19 pulmonary acute respiratory distress syndrome.COVID-19 与非 COVID-19 性急性呼吸窘迫综合征患者顺应性、氧合和通气比值的纵向变化。
Crit Care. 2021 Jul 15;25(1):248. doi: 10.1186/s13054-021-03665-8.
5
Addition of 5% CO to Inspiratory Gas Prevents Lung Injury in an Experimental Model of Pulmonary Artery Ligation.吸入 5%CO 气体可预防肺动脉结扎实验模型中的肺损伤。
Am J Respir Crit Care Med. 2021 Oct 15;204(8):933-942. doi: 10.1164/rccm.202101-0122OC.
6
Management of Adult Patients Supported with Venovenous Extracorporeal Membrane Oxygenation (VV ECMO): Guideline from the Extracorporeal Life Support Organization (ELSO).成人患者静脉-静脉体外膜肺氧合(VV ECMO)支持管理:体外生命支持组织(ELSO)指南。
ASAIO J. 2021 Jun 1;67(6):601-610. doi: 10.1097/MAT.0000000000001432.
7
Ventilatory Variables and Mechanical Power in Patients with Acute Respiratory Distress Syndrome.急性呼吸窘迫综合征患者的通气变量和机械功率。
Am J Respir Crit Care Med. 2021 Aug 1;204(3):303-311. doi: 10.1164/rccm.202009-3467OC.
8
Extracorporeal life support for adults with acute respiratory distress syndrome.体外生命支持治疗成人急性呼吸窘迫综合征。
Intensive Care Med. 2020 Dec;46(12):2464-2476. doi: 10.1007/s00134-020-06290-1. Epub 2020 Nov 2.
9
Incidence and outcomes of acute respiratory distress syndrome in intensive care units of mainland China: a multicentre prospective longitudinal study.中国内地重症监护病房急性呼吸窘迫综合征的发生率和结局:一项多中心前瞻性纵向研究。
Crit Care. 2020 Aug 20;24(1):515. doi: 10.1186/s13054-020-03112-0.
10
Time-varying intensity of mechanical ventilation and mortality in patients with acute respiratory failure: a registry-based, prospective cohort study.机械通气强度随时间变化与急性呼吸衰竭患者死亡率的关系:基于注册的前瞻性队列研究。
Lancet Respir Med. 2020 Sep;8(9):905-913. doi: 10.1016/S2213-2600(20)30325-8. Epub 2020 Jul 28.